Risk Factors Predictive of Right Ventricular Failure After Left Ventricular Assist Device Implantation

American Journal of Cardiology

Volumn 105, Issue 7, 2010, Pages 1030-1035

  Drakos, Stavros G ^a,b,c   Janicki, Lindsay ^a,b   Horne, Benjamin D ^a   Kfoury, Abdallah G ^a,b   Reid, Bruce B ^a,b   Clayson, Stephen ^a   Horton, Kenneth ^a   Haddad, Francois ^d   Li, Dean Y ^b   Renlund, Dale G ^a,b   Fisher, Patrick W ^a,e  

^a INTERMOUNTAIN MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ATHENS   (Greece)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; NITRIC OXIDE;

ADULT; AGED; AORTA BALLOON; ARTICLE; CARDIAC PATIENT; DEATH; FEMALE; HEART ASSIST DEVICE; HEART RIGHT VENTRICLE FAILURE; HUMAN; IMPLANT; LUNG RESISTANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SELECTION; POPULATION; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; STRATIFICATION;

COUNTERPULSATION; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; PROSTHESIS IMPLANTATION; RISK FACTORS; TREATMENT OUTCOME; VASCULAR RESISTANCE; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 77949571229     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.11.026     Document Type: Article

References (21)

1. Rose E., Gelijns A., Moskowitz A., Heitjan D., Stevenson L., Dembitsky W., Long J., Ascheim D., Tierney A., Levitan R., Watson J., Meier P., Ronan N., Shapiro P., Lazar R., Miller L., Gupta L., Frazier O., Desvigne-Nickens P., Oz M., and Poirier V. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
2. Deng M., Edwards L., Hertz M., Rowe A., Keck B., Kormos R., Naftel D., Kirklin J., and Taylor D. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report-2005. J Heart Lung Transplant 24 (2005) 1182-1187
3. Frazier O., Rose E., Oz M., Dembitsky W., McCarthy P., Radovancevic B., Poirier V., and Dasse K. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 122 (2001) 1186-1895
4. Drakos S., Kfoury A., Long J., Stringham J., Gilbert E., Moore S., Campbell B., Nelson K., Horne B., and Renlund D. Effect of mechanical circulatory support on outcomes after heart transplantation. J Heart Lung Transplant 25 (2006) 22-28
5. Dang N., Topkara V., Mercando M., Kay J., Kruger K., Aboodi M., Oz M., and Naka Y. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant 25 (2006) 1-6
6. Furukawa K., Motomura T., and Nosé Y. Right ventricular failure after left ventricular assist device implantation: the need for an implantable right ventricular assist device. Artif Organs 29 (2005) 369-377
7. Kavarana M., Pessin-Minsley M., Urtecho J., Catanese K., Flannery M., Oz M., and Naka Y. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg 73 (2002) 745-750
8. Matthews J., Koelling T., Pagani F., and Aaronson K. The right ventricular failure risk score a preoperative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 51 (2008) 2163-2172
9. Morgan J., John R., Lee B., Oz M., and Naka Y. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg 77 (2004) 859-863
10. Ochiai Y., McCarthy P., Smedira N., Banbury M., Navia J., Feng J., Hsu A., Yeager M., Buda T., Hoercher K., Howard M., Takagaki M., Doi K., and Fukamachi K. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 106 Suppl 1 (2002) I198-I202
11. Fitzpatrick III J.R., Frederick J.R., Hsu V.M., Kozin E.D., O'Hara M.L., Howell E., Dougherty D., McCormick R.C., Laporte C.A., Cohen J.E., Southerland K.W., Howard J.L., Jessup M.L., Morris R.J., Acker M.A., and Woo Y.J. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant 27 (2008) 1286-1292
12. Fitzpatrick III J.R., Frederick J.R., Hiesinger W., Hsu V.M., McCormick R.C., Kozin E.D., Laporte C.M., O'Hara M.L., Howell E., Dougherty D., Cohen J.E., Southerland K.W., Howard J.L., Paulson E.C., Acker M.A., Morris R.J., and Woo Y.J. Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device. J Thorac Cardiovasc Surg 137 (2009) 971-977
13. Copeland J.G., Smith R.G., Bose R.K., Tsau P.H., Nolan P.E., and Slepian M.J. Risk factor analysis for bridge to transplantation with the CardioWest total artificial heart. Ann Thorac Surg 85 (2008) 1639-1644
14. Kirklin J., Naftel D., Stevenson L., Kormos R., Pagani F., Miller M., Ulisney K., and Young J. INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant 27 (2008) 1065-1072
15. Lietz K., Long J., Kfoury A., Slaughter M., Silver M., Milano C., Rogers J., Naka Y., Mancini D., and Miller L. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116 (2007) 497-505
16. Drakos S.G., Charitos E.I., Nanas S.N., and Nanas J.N. Ventricular-assist devices for the treatment of chronic heart failure. Expert Rev Cardiovasc Ther 5 (2007) 571-584
17. Holman W., Kormos R., Naftel D., Miller M., Pagani F., Blume E., Cleeton T., Koenig S., Edwards L., and Kirklin J. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant 28 (2009) 44-50
18. Drakos S., Kfoury A., Gilbert E., Horne B., Long J., Stringham J., Campbell B., and Renlund D. Effect of reversible pulmonary hypertension on outcomes after heart transplantation. J Heart Lung Transplant 26 (2007) 319-323
19. Drakos S., Kfoury A., Gilbert E., Long J., Stringham J., Hammond E., Jones K., Bull D., Hagan M., Folsom J., Horne B., and Renlund D. Multivariate predictors of heart transplantation outcomes in the era of chronic mechanical circulatory support. Ann Thorac Surg 83 (2007) 62-67
20. Unverferth D., Blanford M., Kates R., and Leier C. Tolerance to dobutamine after a 72 hour continuous infusion. Am J Med 69 (1980) 262-266
21. Tohmeh J., and Cryer P. Biphasic adrenergic modulation of beta-adrenergic receptors in man: agonist-induced early increment and late decrement in beta-adrenergic receptor number. J Clin Invest 65 (1980) 836-840